Dr. Hena A. Ansari is a Professor in the Department of Pathology at Jawaharlal Nehru Medical College, Aligarh Muslim University (AMU), Aligarh, India. She has over 20 years of experience in academic pathology, with diagnostic work spanning cytopathology, histopathology, hematology, and clinical pathology.

Her areas of interest include thyroid and breast cytopathology, artificial intelligence in pathology, and medical education (teaching–learning strategies and curriculum design).

• Child & Teen BMI Percentile Calculator (CDC, Ages 2–19) — reviewed for clarity of screening-only interpretation, age/sex range notes, and consistency with CDC growth-chart methodology.

Note: The CV lists additional international and national publications and conference abstracts beyond this selected set.

Supervisor: 23 theses (16 submitted listed in CV; additional theses under supervision also listed).

Submitted theses (as listed)

1. Role of cytomorphology and imaging in prediction of biomarker status of invasive breast carcinoma with emphasis on triple negative breast carcinoma — Dr. Deeba Khan (Submitted 2025).
2. Cytomorphological features predictive of BRAF V600E mutation in thyroid neoplasms and correlation with histopathology and immunochemistry — Dr. Fatima Qaiser Naqvi (Submitted 2025).
3. Thyroid swelling: retrospective and prospective clinicopathological and radiological evaluation — Dr. Shreeshma S (Submitted 2025).
4. Comparative study of Bethesda system, cytological scoring and ACR‑TIRADS for evaluation of thyroid nodules — Dr. Nauris Quamar (Submitted 2024).
5. Tumour budding and its relation with clinicopathological parameters in carcinoma breast — Dr. Saman Usmani (Submitted 2022).
6. Round cell tumours: cyto-histopathological correlation and role of immunohistochemistry — Dr. Mazhar Fahim (Submitted 2022).
7. Breast lesions classification per IAC Yokohama System: retrospective and prospective study — Dr. Kirti Rajput (Submitted 2021).
8. Role of cytopathology, AFB staining and GeneXpert MTB/RIF in tubercular lymphadenopathy — Dr. Saquib Ahmed (Submitted 2020).
9. Ki67 expression in thyroid tumours (follicular patterned neoplasms) — Dr. Smriti Bhaskar (Submitted 2020).
10. CD44 expression in breast carcinoma as a prognostic tumour marker — Dr. Ankita Parashar (2019).
11. p16 expression in premalignant oral intraepithelial lesions and oral squamous cell carcinoma — Dr. Kanika Maheshwari (2019).
12. Malignant lymphomas spectrum with emphasis on CD30 expression — Dr. Shagufta Shahin (2018).
13. Histopathological spectrum of skin lesions (excluding infectious lesions) and role of immunohistochemistry — Dr. Durre Shahwar (2018).
14. Extracellular Matrix Protein‑1 immunochemistry in thyroid neoplasms — Dr. Naba Hasan (2017).
15. Thyroid lesions spectrum and role of immunochemistry (Galectin‑3 and Emerin) — Dr. Anu Agarwal (2016).
16. Estrogen receptor and EGFR in epithelial ovarian neoplasms — Dr. Mahak Wadhwa (2015).

Under supervision (as listed)

1. Cytomorphological evaluation of serous fluids and role of AI in diagnosis of malignant effusions — Dr. Shazia Mazahir (2025).
2. Bone and cartilage lesions: cytopathological classification with risk stratification — Dr. Shivani Pambhoi (2025).
3. Soft tissue tumours: six-tier classification; role of Ki‑67 in risk stratification — Dr Sana Azad (2024).
4. Uterine leiomyomas and variants: clinico-histomorphological study — Dr Azharuddin Ansari (2024).
5. Vitamin D supplementation and ocular surface/tear film parameters in dry eye disease (Co-supervision) — Dr Tahira Aziz (2024).
6. Serum PSA correlation with BMI and Ferriman–Gallwey score in women with PCOS (Co-supervision) — Dr. Zakia Almas (2024).
7. Iron status and morbidity profile of children with cyanotic congenital heart disease (Co-supervisor) — Dr. Abhijeet Kanojia (2024).